OBiO Tech, Inc. 

About OBiO Tech, Inc. 
OBiO Technology (Shanghai) Corp., Ltd. (OBiO, SSE:688238.SH) 
was established in 2013. It is a biotechnology company focusing in the field of gene and cell therapy, providing CRO and CDMO services such as viral  vector development and gene function study for basic research as well as CMC development and GMP manufacture of  plasmids, viral vectors, oncolytic viruses, CAR-T cell therapy products, With "enable gene therapy for better lives" as our mission, we are dedicated to delivering high-quality service to customers worldwide, advancing products from bench to clinic, ultimately bringing benefit to patients around the world. For more information about OBiO, visit www.obio-tech.com.